Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024397 · ClinicalTrials.gov registry record
A Study to Evaluate Unintended Prolonged Opioid Use
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,796
- Enrollment target
NCT04024397: Completed study, sponsored by Mayo Clinic.
NCT04024397 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,796 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04024397 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,796 participants
- Enrollment target
Study Summary
Researchers are trying to better understand how people who are prescribed opioids for short-term use, go on to receive this type of medication on a longer-term basis.
Primary Outcome
At month 6 following the receipt of the initial opioid prescription, the status of opioid use will be assessed to determine the rate of converting to long-term use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,796 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2023-12-29 |
What the finished NCT04024397 record still lists
NCT04024397 is an observational study that tracks outcomes without assigning an intervention. Its 1,796 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04024397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04024397 about?
NCT04024397 is a clinical study titled "A Study to Evaluate Unintended Prolonged Opioid Use". Researchers are trying to better understand how people who are prescribed opioids for short-term use, go on to receive this type of medication on a longer-term basis.
What is the current status of trial NCT04024397?
This trial is currently completed. The enrollment target is 1,796 participants. The study started on 2019-10-01. Estimated completion is 2023-12-29.
Who is sponsoring clinical trial NCT04024397?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI